A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma (Q43293811)
Jump to navigation
Jump to search
scientific article published on 11 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma |
scientific article published on 11 August 2009 |
Statements
1 reference
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma (English)
1 reference
Jeffrey Weber
1 reference
John A Thompson
1 reference
Omid Hamid
1 reference
David Minor
1 reference
Asim Amin
1 reference
Ilan Ron
1 reference
Ruggero Ridolfi
1 reference
Hazem Assi
1 reference
Anthony Maraveyas
1 reference
David Berman
1 reference
Jonathan Siegel
1 reference
Steven J O'Day
1 reference
11 August 2009
1 reference
1 reference
1 reference
Identifiers
1 reference